Communicate with Supplier? Supplier
Su Mr. Su
What can I do for you?
Contact Supplier

HomeNewsQihe biotech applied for listing on the New Third Board

Qihe biotech applied for listing on the New Third Board



On January 14th, Shandong Qihe Biotechnology Co., Ltd. has officially applied for listing on the New Third Board.

The operating income of Qihe Biology in January-October 2015, 2014, and 2013 was 154 million yuan, 162 million yuan,and 78.835 million yuan respectively; net profit was 27.133 million yuan, 36.193 million yuan, and 14.416 million yuan. The announcement shows that the main business of Qihe Biology is the cultivation and sales of edible fungi, and the main products are mushrooms, pleurotus eryngii, and mushroom sticks. Among them, Pleurotus eryngii and Lentinula edodes mainly target the domestic market; Lentinus edodes sticks mainly enter overseas markets such as South Korea, Japan, and the United States. Now through continuous technical exploration and innovation, the company has gradually formed a complete mushroom production technology system. In addition, fresh edible fungi are edible agricultural products. Qihe Bio-factory cultivates edible fungi, which is easy to establish and implement a supervision and management mechanism. The whole process can be controlled from raw materials, environment, production, processing, packaging and distribution, and maximized from the source It avoids the invasion of pathogens, insect pests and environmental pollution to edible fungi, and ensures food safety.

Previous: American customer delegation visits Shandong Qihe Biology

Related Products List